Starling Oncology (STLNW) Gross Profit Growth (1y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Gross Profit Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 3.94% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 27.38% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 10.77% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 18.98% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | - |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 13.08% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | 1.78% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | 0.77% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 55.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.22% |
| Mar 31, 2026 | 35.17% |
| Dec 31, 2025 | 36.69% |
| Sep 30, 2025 | 31.70% |
| Jun 30, 2025 | -66.38% |
| Mar 31, 2025 | -61.81% |
| Dec 31, 2024 | 346.69% |
| Sep 30, 2024 | -61.25% |
| Jun 30, 2024 | 47.28% |
| Mar 31, 2024 | 35.33% |
| Dec 31, 2023 | 13.26% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | 26.03% |
| Mar 31, 2023 | 20.14% |
| Dec 31, 2022 | 32.41% |
| Sep 30, 2022 | 7.32% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | 8.98% |